化学过程工程理学硕士

本课程将利用您现有的科学和工程知识和技能，将其转化为化学工程专业。它将为您提供化学工程和工艺技术方面的最新能力，为行业中令人兴奋且充满挑战的职业铺平道路。从本课程毕业后，您将能够设计，操作和管理流程以及相关的制造工厂。您还将获得创新领导力，技术转让和研发方面的关键技能，这些技能将在您未来的职业中汲取。您将承担一个大型研究项目，并研究一系列必修课，包括化学工程原理，化学过程技术，化学反应过程，分离过程，工厂设计，间歇过程工程以及化学产品设计和开发。
This Masters degree will build upon your existing scientific and engineering knowledge and skills to convert them into a specialisation in chemical engineering. It will provide you with up-to-date competencies in chemical engineering and process technology, paving the way for an exciting and challenging career in the industry. Upon graduating from this course, you will be able to design, operate and manage processes and associated manufacturing plants. You will also gain key skills in innovation leadership, technology transfer and research and development that you will draw on in your future career. You'll undertake a large research project and study a series of compulsory taught modules covering chemical engineering principles, chemical process technology, chemical reaction processes, separation processes, plant design, batch process engineering and chemical products design and development. This course is suitable for graduates of a related engineering or science undergraduate degree, for example in chemistry. If you are a chemical engineering graduate, you might be interested in our Advanced Chemical Engineering MSc.<br><br>A degree from Leeds and the experience you'll gain here will give you the edge to find the career you want. Your course will give you the experience and knowledge that employers are looking for to help you secure a job. The University of Leeds is in the top five most targeted universities in the UK by graduate recruiters, according to High Fliers' The Graduate Market in 2021 report. There is a wide range of career opportunities in the chemical and allied industries in process engineering, process design and research and development as well as in finance and management. Our graduates have secured positions at companies such as: ASM Technologies, BOC, P&G, National Nuclear Industry, Hollister-Stier Laboratories, Pfizer, National Centre of Science and Technology Evaluation and Worley Parsons.